You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-androgen receptor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Acne Vulgaris Trial in Stanford (Clascoterone 1% Top Cream, Vehicle)

    Not yet recruiting
    • Acne Vulgaris
    • Stanford, California
      Stanford University
    Jun 6, 2023

    COVID-19, SARS-CoV2, Androgenetic Alopecia Trial in Brasilia (Proxalutamide, Standard of Care)

    Completed
    Has Results
    • COVID-19
    • +5 more
    • Brasilia, Brazil
      Corpometria Institute
    Dec 8, 2021

    Metastatic Breast Cancer Trial in United States (Orteronel)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • New Haven, Connecticut
    • +9 more
    Jun 8, 2022

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    Therapy of Anti-NMDAR Encephalitis at Diagnosis

    Active, not recruiting
    • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
      • Rotterdam, Netherlands
        Erasmus Medical Center
      Sep 4, 2023

      Breast Cancer Female, Triple Negative and Androgen Receptor Positive Trial in Caen (Darolutamide, Capecitabine)

      Active, not recruiting
      • Breast Cancer Female
      • Triple Negative and Androgen Receptor Positive
      • Caen, France
        Centre François Baclesse
      Jan 3, 2022

      Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

      Recruiting
      • Prostate Cancer
      • +6 more
      • Radiotherapy (SBRT) and/or surgery (metastasectomy)
      • +2 more
      • Leuven, Belgium
        University Hospitals Leuven
      Jun 7, 2022

      Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • +2 more
      • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 10, 2023

      Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

      Recruiting
      • Refractory Multiple Myeloma
      • Relapsed Multiple Myeloma
      • Manufactured Anti-BCMA CAR-T cells
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Jan 6, 2023

      In-vitro Diagnostic Test to Predict COVID-19 Mortality and

      Recruiting
      • SARS-CoV 2
      • +5 more
      • CAG length <22
      • CAG length >=22
      • Madrid, Spain
        Hospital Universitario Ramon y Cajal
      Feb 17, 2022

      Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

      Not yet recruiting
      • Depressive Disorder, Major
      • +2 more
      • New Haven, Connecticut
        Yale University
      Jun 26, 2023

      Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

      Not yet recruiting
      • Depressive Disorder
      • +4 more
      • Perampanel 6 MG
      • +2 more
      • West Haven, Connecticut
        VA Connecticut Healthcare System
      Mar 14, 2023

      Healthy Trial in Qingdao (VDJ001, Placebo)

      Completed
      • Healthy
      • Qingdao, Shandong, China
        the Affliated Hospital of Qingdao University
      Aug 30, 2023

      Clinical-immunological Features of Anti-NMDAR Encephalitis

      Active, not recruiting
      • Anti NMDA Receptor Encephalitis
      • Description of clinical characteristic
      • Lyon, Bron, France
        Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
      Feb 12, 2023

      Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

      Recruiting
      • Prostate Carcinoma
      • +6 more
      • Abiraterone Acetate
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 10, 2022

      Psycho-social Impact of Anti-NMDAR Encephalitis

      Not yet recruiting
      • NMDAR Antibody-associated Auto-immune Encephalitis
      • standardized and validated surveys
      • Bron, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Jul 13, 2023

      Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

      Active, not recruiting
      Has Results
      • Estrogen Receptor Negative
      • +6 more
      • Biomarker Analysis
      • +3 more
      • Birmingham, Alabama
      • +8 more
      Feb 3, 2022

      Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

      Completed
      • Sarcoma
      • +3 more
      • Anti-GD2-CAR engineered T cells
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))

      Recruiting
      • Systemic Lupus Erythematosus (SLE)
      • anti-CD19 CAR NK cells (KN5501)
      • Shanghai, China
        Changhai Hospital
      Aug 25, 2023

      Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)

      Not yet recruiting
      • Follicular Lymphoma
      • Axicabtagene Ciloleucel
      • +5 more
      • (no location specified)
      Sep 21, 2023

      Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

      Not yet recruiting
      • Hormone Receptor-positive Breast Cancer
      • +2 more
      • Nashville, Tennessee
        Sarah Cannon Research Institute
      Oct 5, 2022

      Prostate Cancer Trial in Baltimore (Flutamide, Placebo)

      Recruiting
      • Prostate Cancer
      • Baltimore, Maryland
        SKCCC at Johns Hopkins
      Sep 2, 2021

      Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

      Completed
      • Advanced Epithelial Ovarian
      • +3 more
      • Basking Ridge, New Jersey
      • +5 more
      Mar 4, 2022